Market Cap

Ipsen SA Market Capitalization:

€9.58 Billion

EUR as of Jan. 1, 2026

US$11.25 Billion

business Ipsen SA Company Profile

Ipsen SA Main Stock Listing

Euronext: IPN

Market Capitalization History of Ipsen SA

Market capitalizations are calculated from the opening stock price at the beginning of each month.

Top Competitors by Market Capitalization

Industry: Drug Manufacturers—Specialty & Generic
Company Market Cap (USD)
MERCK Kommanditgesellschaft auf Aktien $62.01 B
Zoetis Inc. $55.81 B
Takeda Pharmaceutical Company Limited $45.42 B
Haleon plc $44.50 B
Teva Pharmaceutical Industries Limited $35.85 B
Sector: Healthcare
Company Market Cap (USD)
Lilly $968.50 B
Johnson & Johnson $499.57 B
AbbVie $405.28 B
Roche $332.12 B
UnitedHealth Group $304.72 B

Yearly evolution of Ipsen SA market cap

Date Market Cap YoY Change
Jan. 1, 2026 €9.58 B 5.82%
Jan. 1, 2025 €9.05 B 1.05%
Jan. 1, 2024 €8.96 B 7.96%
Jan. 1, 2023 €8.30 B 18.42%
Jan. 1, 2022 €7.00 B 19.78%
Jan. 1, 2021 €5.85 B

Market capitalization is calculated from the opening stock price at the beginning of each year.

Ipsen SA Categories

France languages Healthcare languages Drug Manufacturers—Specialty & Generic
France Healthcare France Drug Manufacturers—Specialty & Generic

Stocks & Indices

Ipsen SA has the following listings and related stock indices.


Stock: Euronext: IPN

Stock: FSX: I7G

Stock: OTC: IPSEF

Stock: OTC: IPSEY

What is a company's market capitalization?

The market capitalization of a company, more simply referred to as "market cap", is the total market value of a publicly traded company's outstanding shares. It is often considered as a key indicator of what a company is worth.